JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
+30.47%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$131M
AUM Growth
+$131M
(+198%)
Cap. Flow
+$75.9M
Cap. Flow
% of AUM
58.08%
Top 10 Holdings %
Top 10 Hldgs %
94.04%
Holding
53
New
12
Increased
3
Reduced
16
Closed
17
Top Buys
| 1 |
StoneCo
STNE
|
$38.9M |
| 2 |
NGD
New Gold Inc
NGD
|
$15.5M |
| 3 |
abrdn Physical Platinum Shares ETF
PPLT
|
$12.8M |
| 4 |
XP
XP
|
$10.9M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$713K |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
$988K |
| 2 |
Eli Lilly
LLY
|
$861K |
| 3 |
Telecom Argentina
TEO
|
$853K |
| 4 |
Banco Macro
BMA
|
$834K |
| 5 |
Galicia Financial Group
GGAL
|
$820K |
Sector Composition
| 1 | Technology | 35.86% |
| 2 | Materials | 31.19% |
| 3 | Healthcare | 9.34% |
| 4 | Financials | 8.36% |
| 5 | Communication Services | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
StoneCo
STNE
$4.41B
| $46.9M | 35.84% | 4,472,738 +3,707,941 | +485% | +$38.9M |
|
|
NGD
2
New Gold Inc
NGD
$4.67B
| $39.7M | 30.32% | 10,687,997 +4,187,997 | +64% | +$15.5M |
|
|
3
abrdn Physical Platinum Shares ETF
PPLT
$1.58B
| $12.8M | 9.78% | +140,000 | New | +$12.8M |
|
|
4
XP
XP
$9.56B
| $10.9M | 8.36% | +795,194 | New | +$10.9M |
|
|
ONC
5
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $3.26M | 2.5% | 11,995 +2,621 | +28% | +$713K |
|
6
Incyte
INCY
$16.5B
| $1.17M | 0.9% | 19,332 -5,301 | -22% | -$321K |
|
|
7
Eli Lilly
LLY
$657B
| $1.11M | 0.85% | 1,345 -1,042 | -44% | -$861K |
|
8
Agnico Eagle Mines
AEM
$72.4B
| $704K | 0.54% | 6,497 | – | – |
|
9
AbbVie
ABBV
$372B
| $703K | 0.54% | +3,355 | New | +$703K |
|
10
UnitedHealth
UNH
$281B
| $517K | 0.4% | 987 -393 | -28% | -$206K |
|
11
Acadia Pharmaceuticals
ACAD
$4.38B
| $448K | 0.34% | 26,952 -7,668 | -22% | -$127K |
|
12
Abbott
ABT
$231B
| $444K | 0.34% | +3,346 | New | +$444K |
|
13
Alamos Gold
AGI
$12.8B
| $413K | 0.32% | 15,452 | – | – |
|
14
Madrigal Pharmaceuticals
MDGL
$9.76B
| $411K | 0.31% | 1,241 -752 | -38% | -$249K |
|
15
Bristol-Myers Squibb
BMY
$96B
| $411K | 0.31% | +6,734 | New | +$411K |
|
|
16
Intuitive Surgical
ISRG
$170B
| $404K | 0.31% | 815 -1,995 | -71% | -$988K |
|
17
Johnson & Johnson
JNJ
$427B
| $384K | 0.29% | +2,313 | New | +$384K |
|
18
Thermo Fisher Scientific
TMO
$186B
| $381K | 0.29% | 765 -657 | -46% | -$327K |
|
19
Boston Scientific
BSX
$156B
| $360K | 0.28% | 3,573 -32 | -0.9% | -$3.23K |
|
20
Zoetis
ZTS
$69.3B
| $324K | 0.25% | +1,967 | New | +$324K |
|
21
Summit Therapeutics
SMMT
$17.6B
| $296K | 0.23% | 15,366 -1,714 | -10% | -$33.1K |
|
22
Gilead Sciences
GILD
$140B
| $286K | 0.22% | +2,552 | New | +$286K |
|
23
Vertex Pharmaceuticals
VRTX
$100B
| $283K | 0.22% | 583 -385 | -40% | -$187K |
|
24
Danaher
DHR
$147B
| $278K | 0.21% | 1,354 -1,118 | -45% | -$229K |
|
25
Insmed
INSM
$28.8B
| $240K | 0.18% | 3,147 -2,973 | -49% | -$227K |
|